Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-63.69M -65.77M -60.51M -110.09M
Depreciation & Amortization
-1.11M 169K 159K 105K
Stock-Based Compensation
10.84M 11.95M 9.64M 2.11M
Other Working Capital
n/a 3.62M -1.32M -10.19M
Other Non-Cash Items
-841K -2.62M 2.89M 836K
Deferred Income Tax
n/a n/a n/a 72.38M
Change in Working Capital
n/a -3.4M -1.82M 12.24M
Operating Cash Flow
-59.55M -59.66M -49.64M -22.42M
Capital Expenditures
-1.65M -3.97M -444K -46K
Cash Acquisitions
n/a n/a 132.44M 25.2M
Purchase of Investments
-36.48M -64.44M -145.19M n/a
Sales Maturities Of Investments
63.34M 151.62M 12.75M n/a
Other Investing Acitivies
n/a n/a -132.44M -4.5M
Investing Cash Flow
25.2M 83.21M -132.89M 25.15M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -4.41M
Other Financial Acitivies
130K 326K 120K -8.78M
Financial Cash Flow
130K 326K 72.62M 141.8M
Net Cash Flow
-34.22M 23.87M -109.91M 144.53M
Free Cash Flow
-61.2M -63.63M -50.08M -22.47M